PCRX

Pacira Pharmaceuticals, Inc. News Headlines

$67.72
*  
3.51
 negative 
5.47%
Get PCRX Alerts
*Delayed - data as of Apr. 16, 2014 
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Pacira Prices Offering, Shares Soar - Analyst Blog
4/10/2014 12:00:01 PM - Zacks.com

Pacira Pharmaceuticals (PCRX) Soars: Stock Adds 11.4% in Session - Tale of the Tape
4/10/2014 9:21:01 AM - Zacks.com

Bruised in Market Decline Last Week, Healthcare Stocks Leading Wednesday's Broad-Based Rally
4/9/2014 3:57:33 PM - MT Newswires

Sector Update: Healthcare
4/9/2014 3:54:47 PM - MT Newswires

Pacira and Patheon Collaborate - Analyst Blog
4/8/2014 6:10:01 PM - Zacks.com

Additional Data on Pacira's Exparel - Analyst Blog
4/8/2014 5:20:01 PM - Zacks.com

Sector Update: Healthcare Shares Higher Pre-Market; Alkermes up 11% on Phase 3 Trial Results
4/8/2014 8:40:48 AM - MT Newswires

Sector Update: Healthcare
4/8/2014 8:40:06 AM - MT Newswires

Pacira Pharma Offering $100 Mln Of Stock
4/7/2014 4:45:00 PM - RTT News

Pacira Says FDA Approved Additional Manufacturing Suite For Exparel
3/31/2014 6:45:00 AM - RTT News

Skyepharma Turns To Profit As Revenue Up 25%, Announces Share Sale, Stock Jumps
3/31/2014 3:49:00 AM - RTT News

New Data on Pacira's Exparel - Analyst Blog
3/19/2014 4:45:01 PM - Zacks.com

Sector Update: Healthcare Shares Flat to Lower Pre-Market; Pacira Up 5% on Phase 3 Trial Meeting Endpoints
2/27/2014 9:26:00 AM - MT Newswires

Sector Update: Healthcare
2/27/2014 9:22:40 AM - MT Newswires

Pacira Pharma Says EXPAREL Phase 3 Trial Meets Primary Efficacy Endpoint
2/27/2014 6:39:00 AM - RTT News

Wider-than-Expected Loss at Pacira - Analyst Blog
2/26/2014 1:20:01 PM - Zacks.com

ANIK Needs Your Attention, DARA Gets A Double Blessing, ITMN ASCENDs So High
2/26/2014 1:14:00 AM - RTT News

Sector Update: Healthcares Fairly Flat Pre-Market; Pacira Pharmaceuticals' Q4 Earnings Shy of Street View
2/25/2014 9:40:21 AM - MT Newswires

Sector Update: Healthcare
2/25/2014 9:39:53 AM - MT Newswires

Update on Pacira's Exparel - Analyst Blog
1/30/2014 6:50:01 PM - Zacks.com

Is Pacira Pharmaceuticals (PCRX) Stock a Solid Choice Right Now? - Tale of the Tape
1/17/2014 9:50:01 AM - Zacks.com

New Data on Pacira's Exparel - Analyst Blog
1/8/2014 7:11:01 PM - Zacks.com

Update on Pacira's Exparel - Analyst Blog
12/6/2013 7:04:54 PM - Zacks.com

Risk/Reward Remains Positive For Durect
11/5/2013 9:18:00 AM - Seeking Alpha

Wider-than-Expected Loss at Pacira - Analyst Blog
11/4/2013 3:00:01 PM - Zacks.com